Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation
Bechstein, W.O.; Neuhaus, P.; McMaster, P.; Calne, R.; Pichlmayr, R.; Otto, G.; Williams, R.; Ericzon, B.G.; Bismuth, H.
Transplantation Proceedings 28(2): 1008-1010
1996
ISSN/ISBN: 0041-1345 PMID: 8623211 Document Number: 464471
Document emailed within 1 workday
Related Documents
Arnold, J.C.; Theilmann, L. 1995: Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation Zeitschrift für Gastroenterologie 33(10): 624-625Eckhoff, D.E.; McGuire, B.M.; Frenette, L.R.; Contreras, J.L.; Hudson, S.L.; Bynon, J.S. 1998: Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation Transplantation 65(2): 180-187
Neuhaus, P.; Klupp, J.; Langrehr, J.M.; Neumann, U.; Gebhardt, A.; Pratschke, J.; Tullius, S.G.; Lohmann, R.; Radke, C.; Rayes, N.; Neuhaus, R.; Bechstein, W.O. 2000: Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial Transplantation 69(11): 2343-2353
Gayowski, T.; Marino, I.R.; Singh, N.; Doyle, H.R.; Wagener, M.M.; Todo, S.; Fung, J.J.; Starzl, T.E. 1996: Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression Surgical Technology International 5: 223-232
Tanaka, M.; Otobe, Y.; Hashimoto, T.; Shimizu, Y.; Suzuki, T.; Nakamura, Y.; Itoh, K.; Satoh, M.; Ueda, N.; Manabe, T. 1996: Reduction of immunosuppressive agents after living related donor liver transplantation Transplantation Proceedings 28(4): 2402-2403
Heering, P.; Westhoff, A.; Ivens, K.; Kutkuhn, B.; Grabensee, B. 1994: Reduction of immunosuppressive therapy after renal transplantation: a randomized study Transplantation Proceedings 26(5): 2530-2532
Rodriguez Rilo, H.L.; Subbotin, V.M.; Selby, R.R.; Thomson, A.W. 1995: Rapid hair regrowth in refractory alopecia universalis associated with autoimmune disease following liver transplantation and tacrolimus (FK506) therapy Transplantation 59(9): 1350-1353
Gugenheim, J.; Samuel, D.; Saliba, F.; Castaing, D.; Bismuth, H. 1987: Use of flexible triple-drug immunosuppressive therapy in liver transplantation Transplantation Proceedings 19(5): 3805-3807
Wonigeit, K.; Nashan, B.; Schwinzer, R.; Schlitt, H.J.; Kurrle, R.; Racenberg, J.; Seiler, F.; Ringe, B.; Pichlmayr, R. 1989: Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation Transplantation Proceedings 21(1 Part 2): 2258-2259
Tanabe, K.; Koga, S.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Babazono, T.; Yagisawa, T.; Toma, H.; Kawai, T.; Fuchinoue, S.; Teraoka, S.; Ota, K. 1996: Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression Transplantation Proceedings 28(3): 1304-1305
Ganapiev, A.A.; Golubovskaia, I.K.; Zalialov, I.R.; Estrina, M.A.; Afanas'ev, B.V. 2010: The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia Terapevticheskii Arkhiv 82(7): 48-52
Soin, A.S.; Jamieson, N.V. 1996: Lessons learnt from the multicentre randomized trials of tacrolimus in liver transplantation National Medical Journal of India 9(5): 224-226
Yokoyama, I.; Todo, S.; Iwatsuki, S.; Starzl, T.E. 1990: Liver transplantation in the treatment of primary liver cancer Hepato-Gastroenterology 37(2): 188-193
Fu, X.-H.; Ye, Y.-F.; Luo, M.-J.; Hong, X.-D.; Chen, X.-L.; Yao, Q.-Y.; Rong, Y.-C.; Ren, B. 2012: Prediction of blood tacrolimus concentration in liver transplantation recipients by artificial neural network Yao Xue Xue Bao 47(9): 1134-1140
Boillot, O.; Viale, J.P.; Gratadour, P.; Meeus, P.; Souraty, P.; Le Derf, Y.; Mechet, I.; Scoazec, J.Y.; Berger, F.; Paliard, P. 1998: Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study Transplantation 66(9): 1182-1185
Farges, O.; Samuel, D.; Bismuth, H. 1994: Optimal immunosuppressive clinical regimen in liver transplantation Transplantation Proceedings 26(5): 2676-2678
Seybold, D.; Gessler, U.; Sigel, A. 1982: Immunosuppressive therapy following kidney transplantation Der Urologe. Ausg. a 21(5): 274-279
Thomas, H.C. 1989: Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers: implications for the treatment of chronic HBV carriers Quarterly Journal of Medicine 73(270): 873-874
Pilmore, H.L.; Faire, B.; Dittmer, I. 2001: Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature Transplantation 72(10): 1703-1705
Metalidis, C.; Kuypers, D. 2011: Immunosuppressive therapy after kidney transplantation: current and new strategies Minerva Urologica e Nefrologica 63(1): 1-19